Physician profile
Candyce Little
NPI 1609228642
$1,010.49
in general payments reported to CMS, 2019-2025
22 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $303 · 2023: $252 · 2024: $138 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $191.27 | 2024-2025 | Daxxify |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.40 | 2021-2023 | Lifevest |
| Galderma Laboratories, L.P. | $128.06 | 2023-2025 | Dysport |
| Atricure, INC. | $82.93 | 2021-2025 | Atriclip Laa Exclusion System |
| Davol INC. | $80.88 | 2021-2022 | |
| Elutia, INC. | $38.95 | 2022 | |
| Silk Road Medical, INC. | $38.65 | 2022 | |
| Baxter Healthcare | $34.39 | 2022 | |
| Irhythm Technologies, INC. | $30.85 | 2023 | Zio Xt Patch |
| Potrero Medical, INC. | $26.49 | 2023 | |
| Merz North America, INC. | $24.70 | 2023 | Xeomin |
| Lemaitre Vascular, INC. | $24.57 | 2022 | |
| Novo Nordisk INC | $20.60 | 2025 | Wegovy |
| Azurity Pharmaceuticals, INC. | $19.78 | 2023 | Nymalize |
| Smith+Nephew, INC. | $19.55 | 2023 | Renasys Go V2 Home |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.25 | 2023 | |
| Lilly USA, LLC | $16.66 | 2024 | Zepbound |
| Kci USA, INC. | $15.99 | 2021 | |
| Getinge USA Sales, LLC | $15.43 | 2022 | |
| Pfizer INC. | $14.47 | 2022 | |
| Chiesi USA, INC. | $13.32 | 2022 | |
| La Jolla Pharmaceutical Company | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candyce Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.